Douglas Weckstein

1 ta ish

Texas Oncology

1. Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

   Guru Sonpavde, Phillip Periman, D. M. Bernold +8

   MaqolaOAOchiq kirish20092 iqtibos

   ABIABI:AkademIndex/2026.other.011725